Literature DB >> 21982772

Role of the p21-activated kinases (PAKs) in influenza A virus replication.

Philippe Noriel Q Pascua1, Jun-Han Lee, Min-Suk Song, Soo-Jin Park, Yun Hee Baek, Byung-Hoon Ann, Eun-Young Shin, Eung-Gook Kim, Young-Ki Choi.   

Abstract

Influenza A virus infection stimulates a wide range of virus-supportive or antiviral mechanisms in host cells. p21-Activated kinase 1 (PAK1) is a serine/threonine kinase that regulates a number of fundamental cellular processes and has been implicated in the modulation of virus replication. Here, we investigated the role of PAK1 activation during influenza A virus infection and found that virus propagation corresponded to stimulated PAK1 phosphorylation. Moreover, transfection of the active form of PAK1 (PAK1-T423E) in A549 cells induced higher viral titers (∼10-fold differences) compared to that in the control vector or inactive PAK1 (PAK1-K299R)-transfected cells. PAK1-specific siRNA knockdown also resulted in 10-100-fold reductions in virus yields compared to that in the control siRNA-treatment (p<0.05). We further showed that treatment with PAK18, a PAK1 peptide inhibitor, resulted in marked suppression of both ERK 1/2 phosphorylation and infectious virus production, which was comparable to that by U0126, a specific MEK/ERK inhibitor. These results provide evidence for the importance of PAK1 activation during influenza virus infection and its association with ERK in regulating virus replication. The present study also implicates PAK1 as a potential therapeutic target for managing influenza virus infections.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21982772     DOI: 10.1016/j.bbrc.2011.09.119

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  10 in total

Review 1.  Rho'ing in and out of cells: viral interactions with Rho GTPase signaling.

Authors:  Céline Van den Broeke; Thary Jacob; Herman W Favoreel
Journal:  Small GTPases       Date:  2014-03-24

2.  Inhibition of viral and bacterial trigger-stimulated prostaglandin E2 by a throat lozenge containing flurbiprofen: An in vitro study using a human respiratory epithelial cell line.

Authors:  Rob Lambkin-Williams; Alex Mann; Adrian Shephard
Journal:  SAGE Open Med       Date:  2020-09-24

Review 3.  Compounds with anti-influenza activity: present and future of strategies for the optimal treatment and management of influenza. Part I: Influenza life-cycle and currently available drugs.

Authors:  R Gasparini; D Amicizia; P L Lai; N L Bragazzi; D Panatto
Journal:  J Prev Med Hyg       Date:  2014-09

Review 4.  The Influenza Virus Polymerase Complex: An Update on Its Structure, Functions, and Significance for Antiviral Drug Design.

Authors:  Annelies Stevaert; Lieve Naesens
Journal:  Med Res Rev       Date:  2016-08-29       Impact factor: 12.944

Review 5.  The significance of bioengineered nanoplatforms against SARS-CoV-2: From detection to genome editing.

Authors:  Parichehr Hassanzadeh
Journal:  Life Sci       Date:  2021-03-04       Impact factor: 6.780

6.  Evidence of a dysregulated vitamin D endocrine system in SARS-CoV-2 infected patient's lung cells.

Authors:  Bijesh George; Revikumar Amjesh; Aswathy Mary Paul; T R Santhoshkumar; Madhavan Radhakrishna Pillai; Rakesh Kumar
Journal:  Sci Rep       Date:  2021-04-21       Impact factor: 4.379

7.  PAK in pathogen-host interactions.

Authors:  Jean-Philippe Semblat; Christian Doerig
Journal:  Cell Logist       Date:  2012-04-01

Review 8.  Subverting Host Cell P21-Activated Kinase: A Case of Convergent Evolution across Pathogens.

Authors:  Simona John Von Freyend; Terry Kwok-Schuelein; Hans J Netter; Gholamreza Haqshenas; Jean-Philippe Semblat; Christian Doerig
Journal:  Pathogens       Date:  2017-04-21

9.  Influenza A Virus Facilitates Its Infectivity by Activating p53 to Inhibit the Expression of Interferon-Induced Transmembrane Proteins.

Authors:  Bei Wang; Tze Hau Lam; Mun Kuen Soh; Zhiyong Ye; Jinmiao Chen; Ee Chee Ren
Journal:  Front Immunol       Date:  2018-05-31       Impact factor: 7.561

Review 10.  SARS-CoV-2/COVID-19: Viral Genomics, Epidemiology, Vaccines, and Therapeutic Interventions.

Authors:  Mohammed Uddin; Farah Mustafa; Tahir A Rizvi; Tom Loney; Hanan Al Suwaidi; Ahmed H Hassan Al-Marzouqi; Afaf Kamal Eldin; Nabeel Alsabeeha; Thomas E Adrian; Cesare Stefanini; Norbert Nowotny; Alawi Alsheikh-Ali; Abiola C Senok
Journal:  Viruses       Date:  2020-05-10       Impact factor: 5.048

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.